Tvp22 01 omslag kijk verder

Keywords register: clozapine

Review article


T. van der Poorten, M. De Hert

Sublingual use of atropine for clozapine-induced sialorrhoea: literature review and two case reports, 403 - 410

Klinische Praktijk


H.C. van Mierlo, C.D. Schubart, N.M.S. Golüke, K.M. Bessembinders, J.K. Tijdink

Acute dystonia in a patient with an elevated clozapine level due to an infection, 843 - 847

Case report


T.S.E. Nonner, S.J. Timmer

Clozapine and the electronic cigarette; a case study, 314 - 317

Review article


C.W. Slotema, J.D. Blom, I.E.C. Sommer

Treatment strategies for auditory verbal hallucinations, 247 - 256

Case report


A. Archie, P. Persoons, M. Vandenbulcke

The use of clozapine and levodopa for the treatment of persistent visual hallucinations and parkinsonism in Lewy body dementia, 287 - 291

Review article


M.E.H. Wigard, A.R. van Gool, P.F.J. Schulte

Addition of fluvoxamine to clozapine: theory and practice, 113 - 121

Case report


S. van Zuilekom, H.J. Gijsman

A patient on clozapine in the general hospital: the need for discussion between specialists from different disciplines and for close monitoring of the patient’s plasma level, 955 - 959

Case report


W.J.D.M. Laan, D. Ramlal

A case study; ethnicity and clozapine, a risky combination?, 829 - 833

Case report


D. van Dam, T.M. Bosch, E.J. Mookhoek, J.E. Hovens

Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis, 285 - 289

Case report


A.J.E. Visscher, D. Cohen

Peri-orbital oedema and therapy-resistant hypertension: unusual side-effects of clozapine, 555 - 559

New research


H. Kamphuis, J. Arends, L. Timmerman, J. van Marle, J. Kappert

Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy, 223 - 233

Case report


A.R. van Gool, M.H. de Jong, W.M.A. Verhoeven

Toxic plasma concentration of clozapine in inflammatory processes , 791 - 796

Case report


D. Cohen

Clozapine screening: white bloodcell counts no longer sufficient , 785 - 790

Case report


A. Ruissen, A.M. van Schaik, J.H. Beijnen

Clozapine use and abrupt smoking cessation; a potentially life-threatening combination , 699 - 703

Case report


J.M.P. Kleinen, F. Bouckaert, J. Peuskens

Clozapine-induced agranulocytosis and Sweet's syndrome in a 74-year-old female patient. A case study , 119 - 123

Case report


M.R. Koerhuis, A. Wunderink, W.A. Nolen

The treatment of psychotic depression in patients insufficiently responsive to conventional medication and electroconvulsive therapy; what are the options?, 107 - 112

Case report


A.R. van Gool, M.T. van der Velden, A.W. Oosten, E. van Meerten, W.M.A. Verhoeven, A.J.M. Loonen

Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?, 673 - 678

Case report


J.A.W. Benckhuijsen, I.P.M. Keet

Delirium on re-starting clozapine after a short break in treatment , 661 - 665

Case report


P.J.S. Michielsen, M.M. Thunnissen, B. Van Den Bossche

Clozapine and selective serotonin reuptake inhibitors: risks of toxicity , 655 - 659

Case report


J.P.A.M. Bogers

Clozapine and agranulocytosis: should treatment be continued?, 575 - 579

Review article


W.F. Scholte

Clozapine-induced agranulocytosis: genetic risk factors and an immuno-toxic explanatory model, 295 - 302

Short report


V. Christiaens, G. Pieters

Clozapine-induced hypersalivation: causes and suggestions for treatment , 39 - 44

Case report


J.J. Peetoom, P.F.J. Schulte

Flumazenil possibly efficacious in patients in a coma caused by clozapine in combination with benzodiazepines, 185 - 190

Case report


R. Veltkamp, L.H.W.M. Kaiser

Clozapine and fluvoxamine together: more than two times alone. A case study, 347 - 351

Short report


P.F.J. Schulte

The place of clozapine in the treatment of schizophrenia, 715 - 720